Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.75 |
| ▸ | FAAH | O00519 | 2/20 | 0.71 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.63 |
| ▸ | RAD52 | P43351 | 1/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
| ▸ | DGKA | P23743 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | HTR2C | P28335 | 1/20 | 0.58 |
| ▸ | ACHE | P22303 | 6/20 | 0.55 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2215672 | 1.00 | NAAA (0.75) | NAAAFAAHEPHX1RAD52NPSR1 | |
| SCHEMBL3209973 | 1.00 | NAAA (0.75) | NAAAFAAHEPHX1RAD52NPSR1 | |
| SCHEMBL3711322 | 1.00 | NAAA (0.75) | NAAAFAAHEPHX1RAD52NPSR1 | |
| SCHEMBL240374 | 1.00 | NAAA (0.75) | NAAAFAAHEPHX1RAD52NPSR1 | |
| SCHEMBL2976989 | 1.00 | NAAA (0.75) | NAAAFAAHEPHX1RAD52NPSR1 | |
| SCHEMBL3209842 | 1.00 | NAAA (0.75) | NAAAFAAHEPHX1RAD52NPSR1 | |
| SCHEMBL1982370 | 1.00 | NAAA (0.75) | NAAAFAAHEPHX1RAD52NPSR1 | |
| SCHEMBL17812546 | 1.00 | NAAA (0.75) | NAAAFAAHEPHX1RAD52NPSR1 | |
| SCHEMBL207689 | 1.00 | NAAA (0.75) | NAAAFAAHEPHX1RAD52NPSR1 | |
| SCHEMBL3713011 | 1.00 | NAAA (0.75) | NAAAFAAHEPHX1RAD52NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105287363-B | It is a kind of can in-situ injection Low-molecular weight organogel and preparation method and application | 赣南师范学院 | 2018-06-26 | — | — | CN | claimed |
| CN-105287363-A | Micromolecular organic gel for orthotopic injection and preparation method and application thereof | GANNAN NORMAL UNIVERSITY | 2016-02-03 | — | — | CN | claimed |
| WO-2012107116-A1 | CHEMICAL METHOD FOR REMOVING COPPER SULPHIDE (CU2S) DEPOSITED ONTO CELLULOSE -BASED MATERIAL IN TRANSFORMER USING A COPPER COMPLEXANT | ABB RESEARCH LTD (CH) | 2012-08-16 | — | — | WO | claimed |
| EP-2460898-A1 | Chemical method for removing copper sulphide (Cu2S) deposited onto insulating material in a transformer | ABB Research Ltd. (CH) | 2012-06-06 | — | — | EP | claimed |
| CN-101802948-A | tandem photovoltaic cell | BASF SE | 2010-08-11 | — | — | CN | claimed |
| EP-0657522-B1 | Salt compositions and functional fluids using same | LUBRIZOL CORP (US) | 1999-09-29 | — | — | EP | claimed |
| US-5670081-A | Salt compositions and functional fluids using same | THE LUBRIZOL CORPORATION (US) | 1997-09-23 | — | — | US | claimed |
| US-5527491-A | METAL-CONTAINING COMPLEX FORMED BY REACTING HIGH MOLECULAR WEIGHT HYDROCARBYL-SUBSTITUTED ACID DERIVATIVE WITH AMINE, THEN WITH SALT OF PHOSPHORUS-CONTAINING ACID | THE LUBRIZOL CORPORATION (US) | 1996-06-18 | — | — | US | claimed |
| EP-0408838-B1 | Emulsifiers and explosive emulsions containing same | LUBRIZOL CORP (US) | 1996-01-17 | — | — | EP | claimed |
| EP-0657522-A2 | Salt compositions and functional fluids using same | THE LUBRIZOL CORPORATION (US) | 1995-06-14 | — | — | EP | claimed |
| US-5422024-A | Aqueous functional fluids | THE LUBRIZOL CORPORATION (US) | 1995-06-06 | — | — | US | claimed |
| US-5129972-A | An oxygen supply component, an organic phase and a carbon fuel | THE LUBRIZOL CORPORATION (US) | 1992-07-14 | — | — | US | claimed |
| US-5047175-A | Salt composition and explosives using same | THE LUBRIZOL CORPORATION (US) | 1991-09-10 | — | — | US | claimed |
| EP-0408838-A1 | Emulsifiers and explosive emulsions containing same | The Lubrizol Corporation (US) | 1991-01-23 | — | — | EP | claimed |
| EP-0346452-A1 | SALT COMPOSITIONS AND EXPLOSIVES USING SAME | The Lubrizol Corporation (US) | 1989-12-20 | — | — | EP | claimed |
| WO-1989005786-A1 | SALT COMPOSITIONS AND EXPLOSIVES USING SAME | THE LUBRIZOL CORPORATION (US) | 1989-06-29 | — | — | WO | claimed |
| US-4828633-A | EMULSIFIERS IN CAP-SENSITIVE EXPLOSIVE EMULSIONS | THE LUBRIZOL CORPORATION (US) | 1989-05-09 | — | — | US | claimed |
| US-20260062580-A1 | REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT | THE PILOT INK CO., LTD. (JP) | 2026-03-05 | — | — | US | disclosed |
| US-4235786-A | REACTION OF POLYISOBUTYLENE AND MALEIC ANHYDRIDE | EXXON RESEARCH & ENGINEERING CO. (US) | 1980-11-25 | — | — | US | disclosed |
| EP-0014288-A1 | Process for producing oil soluble derivatives of unsaturated C4-C10 dicarboxylic acid materials | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1980-08-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062580-A1 | REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT | TYR, SCO2, HBB | NAAA 4573/4885FAAH 4333/4885EPHX1 3932/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.